MedTrace Logo

Alpine vs. Xpedition: Evaluation of Stent Delivery System

NCT03451617 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2018-03-02

No results posted yet for this study

Summary

To evaluate and compare the performance of two stent delivery systems for percutaneous coronary intervention with everolimus-eluting stent.

Conditions

  • Percutaneous Coronary Intervention

Interventions

DEVICE

Stent delivery with Xpedition

Use of Xpedition stent delivery system to implant the XIENCE stent

DEVICE

Stent delivery with Alpine

Use of Alpine stent delivery system to implant the XIENCE stent

Sponsors & Collaborators

  • Abbott

    collaborator INDUSTRY

  • University of Groningen

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-05
Primary Completion
2019-10-05
Completion
2020-10-05
FDA Device
Yes

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03451617 on ClinicalTrials.gov